Lama Rawat Inap Pasien Terkonfirmasi COVID-19 di Rumah Sakit Universitas Indonesia dan Faktor yang Mempengaruhinya.

Rizka Fahmia, Helda Helda, Astuti Yuni Nursari

Abstract


Banyaknya kasus COVID-19 membuat daya tampung fasilitas kesehatan hampir tidak mencukupi untuk memberikan pelayanan medis rawat inap yang memadai pada pasien COVID-19. Studi yang dilakukan di beberapa negara seperti China, Beijing, Vietnam, Amerika Serikat melaporkan durasi dan faktor resiko rawat inap pasien COVID-19 yang bervariasi. Namun, saat ini penelitian tentang durasi dan faktor resiko lama rawat inap pasien COVID-19 di Indonesia masih terbatas. Penelitian ini bertujuan mengetahui faktor resiko lama rawat inap pasien terkonfirmasi COVID-19 di Rumah Sakit Universitas Indonesia (RSUI). Desain studi potong lintang dilakukan pada 266 pasien terkonfirmasi COVID-19 yang dirawat inap di RSUI selama Maret sampai dengan September 2020. Studi ini menilai faktor resiko usia, jenis kelamin, area tinggal, gambaran radiologi, pekerjaan, gejala, keparahan penyakit, komorbiditas, jumlah obat pada hari pertama rawat, dan status PCR saat akhir rawat. Data berasal dari rekam medis elektronik RSUI. Analisa data melalui uji chi square, Kruskal-Walis dilakukan untuk melihat perbedaan variabel kategorik dan numerik. Selain itu, analisa multivariat regresi logistik dilakukan untuk menentukan prediktor lama rawat inap pasien terkonfirmasi COVID-19 di RSUI. Hasil penelitian didapatkan bahwa median lama rawat inap adalah 13 hari (range 3 – 74 hari). Adapun prediktor rawat inap lebih panjang (>14 hari) adalah pada pria (OR 1,80, 95%CI  1,03 – 3,15), dan pasien dengan gambaran pneumonia (OR 1,68, 95%CI  0,95 – 3,00), diabetes mellitus (OR 3,48, 95%CI  1,11 – 10,92), demam (OR 2,30, 95%CI  1,31 – 4,05), anosmia (OR 4,10, 95%CI  1,60 – 10,48), keparahan sedang (OR 1,64, 95%CI  0,88 – 3,06), keparahan berat (OR 13,31, 95%CI  1,64 – 107,72). Disimpulkan bahwa tingkat keparahan berat, anosmia, diabetes mellitus, demam, pasien pria dan gambaran pneumonia merupakan faktor resiko signifikan yang berhubungan dengan lama rawat inap pasien terkonfirmasi COVID-19 di RSUI Depok. Pasien dengan faktor resiko tersebut diatas untuk lebih diprioritaskan dalam penanganan medis karena rentan terhadap lama rawat inap yang panjang.

Keywords


COVID-19, SARS COV2, faktor resiko, durasi hospitalisasi, rawat inap COVID-19

Full Text:

PDF

References


World Health Organization. Coronavirus Update. https://www.who.int/health-topics/coronavirus#tab=tab_1.

Coronavirus Update (Live): 128,808,498 Cases and 2,816,038 Deaths from COVID-19 Virus Pandemic - Worldometer. https://www.worldometers.info/coronavirus/?%23countries#countries. Accessed March 31, 2021.

Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed March 31, 2021.

Kota Depok I Covid-19. https://ccc-19.depok.go.id/. Accessed March 31, 2021.

Rees EM, Nightingale ES, Jafari Y, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. medRxiv. 2020:2020.04.30.20084780. doi:10.1101/2020.04.30.20084780

Zhao W, Yu S, Zha X, et al. Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study. 2020;(April). doi:10.1101/2020.03.13.20035436

Surendra H, Elyazar IRF, Djaafara BA, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study. medRxiv. 2020.

wang zhuo, Ji JS, Liu Y, et al. Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China. medRxiv. 2020:2020.04.07.20057299. doi:10.1101/2020.04.07.20057299

Ko JY, Danielson ML, Town M, et al. Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. medRxiv. January 2020:2020.07.27.20161810. doi:10.1101/2020.07.27.20161810

Thai PQ, Son DT, Van HTH, et al. Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis. Epidemiol Infect. 2020;148.

Liu X, Zhou H, Zhou Y, et al. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect. 2020;81(1):e95-e97.

Channel RSUI. Tema : Pengalaman RSUI Sebagai RS Rujukan COVID-19. Indonesia; 2020. https://www.youtube.com/watch?v=K8hEQb1yTmU.

Keputusan Menteri Kesehatan Republik Indonesia. HK.01.07/MENKES/247/2020 Tentang Pedoman pencegahan dan pengendalian. 2020;2019:1-127.

Keputusan Menteri Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Corona Virus Disease 2019 (Covid-19). MenKes/413/2020. 2020;2019:207.

Siordia JA. Epidemiology and clinical features of COVID-19: A review of current literature. J Clin Virol. 2020;127(April):104357. doi:10.1016/j.jcv.2020.104357

McQueenie R, Foster H, Jani BD, et al. Multimorbidity, Polypharmacy, and COVID-19 infection within the UK Biobank cohort. medRxiv. 2020:2020.06.10.20127563. doi:10.1101/2020.06.10.20127563

Wu Y, Hou B, Liu J, Chen Y, Zhong P. Risk Factors Associated With Long-Term Hospitalization in Patients With COVID-19: A Single-Centered, Retrospective Study. Front Med. 2020;7:315. doi:10.3389/fmed.2020.00315

Wu S, Xue L, Legido-Quigley H, et al. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital. PLoS One. 2020;15(10):e0240959. https://doi.org/10.1371/journal.pone.0240959.

Symptoms of coronavirus. US Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html%0APublished 2020. Published 2020. Accessed April 27, 2020.

Talavera B, García-Azorín D, Martínez-Pías E, et al. Anosmia is associated with lower in-hospital mortality in COVID-19. J Neurol Sci. 2020;419:117163. doi:10.1016/j.jns.2020.117163

Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngol Neck Surg. 2020(1):3-11. doi:10.1177/0194599820926473

Ji W, Zhang J, Bishnu G, et al. Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis. medRxiv. January 2020:2020.03.04.20030965. doi:10.1101/2020.03.04.20030965

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3

Yaribeygi H, Sathyapalan T, Jamialahmadi T, Sahebkar A. The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions. Chiefari E, ed. J Diabetes Res. 2020;2020:5436832. doi:10.1155/2020/5436832

Menezes Soares R de C, Mattos LR, Raposo LM. Risk Factors for Hospitalization and Mortality due to COVID-19 in Espírito Santo State, Brazil. Am J Trop Med Hyg. 2020;103(3):1184-1190. doi:10.4269/ajtmh.20-0483

Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. January 2020:2020.01.26.919985. doi:10.1101/2020.01.26.919985

Li K, Wu J, Wu F, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Invest Radiol. 2020;55(6):327-331. doi:10.1097/RLI.0000000000000672




DOI: http://dx.doi.org/10.7454/epidkes.v6i1.5004

Refbacks

  • There are currently no refbacks.